AstraZeneca Vaccine | Precautions remain the same in Quebec

The benefits of the AstraZeneca vaccine are still far greater than its risks, according to an investigation by the European Medicines Agency (EMA) on Thursday, however, it has reported symptoms that should prompt vaccinated patients to seek medical help. Quebec Health Minister Christian Dube said he is relying first on his experts, while in Ottawa, an agreement is being negotiated through which the United States can loan 1.5 million doses of this vaccine to Canada.

Ariane KrollAriane Kroll

Henri Owlet VizinaHenri Owlet Vizina

Melanie MarquezMelanie Marquez

Ariane LacursierAriane Lacursier

“It’s a beautiful European experience, but I depend a lot on public health [du Québec] “Mr. Duby was suspended after being vaccinated at the Palais des Congrès in Montreal on Thursday afternoon.

The head of the EMA Risk Assessment Committee, Chair of the EMA Risk Assessment Committee, summarized, “There is no increase in the overall risk of blood clots with this vaccine,” but “there are still doubts.”Return Sabine Strauss, Thursday.

Of the nearly 20 million people who were vaccinated, the European survey recorded 18 cases of thrombosis in the blood vessels that drain blood from the brain (CVST) and seven cases of diffuse intravascular thrombosis (DIC). Nine of these cases resulted in deaths, the majority of them women, and most of them were under the age of 55. The EMA has warned that the reported cases of those under the age of 50 during the period covered by the survey are more than one would expect in patients who have not received the vaccine, but that this reference rate is difficult to estimate as these are rare cases. .

See also  There are too many cats to adopt at the Quebec Spa

Consequently, the data “is not sufficient to conclude whether these adverse events are due to the vaccine or not,” but the situation will be closely monitored, according to Dr.Return Strauss.

Therefore the EMA recommended that vaccinated patients seek immediate medical care for symptoms such as shortness of breath, chest or stomach pain, swelling or coldness in an arm or leg, blurred vision, headache that is severe or that worsens after the vaccination, or bleeding. Persistent, or small bruising, red or purple spots, small bleeding spots under the skin (petechiae).

In Quebec, regardless of the vaccine that is received, “there is a follow-up by the public health to the so-called exceptions, so what happens when a person suffers from a blood clot or something else”, Minister Christian Dube stated, noting that these cases “are sent to the central registry.” To be taken into account. ”

Photo by David Boiley, press

Health Minister Christian Dube after receiving his first dose of AstraZeneca vaccine on Thursday

Case of thrombosis in Monterge

Last Sunday, a 79-year-old man from Montergue received a dose of AstraZeneca vaccine in the morning and had to be hospitalized a few hours later, suffering from a cerebral venous thrombosis. One of his relatives said that he is being treated in intensive care, but that his life is not feared. However, he will have to undergo one month of rehabilitation. The man in question has had multiple strokes in the past, according to this relative, who does not understand that despite this history, we still decide to give the AstraZeneca vaccine. Should we not adopt the precautionary principle in such a situation? Asks the patient’s relative, who states that a report of the harmful incident has been filed with Health Canada.

See also  Moscow denounces Johnson's "rude" comments towards Putin

When asked if the case of this patient from Monterige had prompted the government to re-study the AstraZeneca vaccine, Christian Dube replied on Thursday afternoon: “No, not at all. There will be cases like this. That could happen, it is roughly 4 cases out of 100,000. So, there will definitely be some… The patient’s relative from Monterge considers this response “unacceptable.”

It makes no sense not to take special precautions.

A relative of a patient who developed a blood clot after receiving a vaccine

In Quebec’s Department of Health and Social Services, it has been reported that, to date, 82,204 doses of the AstraZeneca vaccine, called Covishield, have been administered in Quebec and that “no unusual clinical manifestations (ICD), such as a thrombotic or serious event,” have not been Report it. The ministry asserts that “at the present time there is no indication of the state of blood clots [dont a été victime le patient de la Montérégie] Or with regard to administering the Coffeeshield vaccine. ”

To date, the Canadian Department of Health reported that “more than 3.4 million doses of COVID-19 vaccines have been administered in Canada and no safety concerns have been reported.”

In all, eight reports of thromboembolic events were submitted to Health Canada, six for people who received the Pfizer / BioNTech vaccine, one for the Moderna vaccine and one for the AstraZeneca vaccine. “There is no evidence at present that these incidents are related to the vaccine,” says the Canadian Ministry of Health, adding that “there are no reported effects that indicate that the vaccine suffers from a safety problem.”

See also  Possible visit to Taiwan | Justin Trudeau argues that parliamentarians will take into account the possible consequences

Health Canada notes that “these types of thromboembolic events (such as strokes) are not unexpected in some of the major population groups that have been prioritized in the first months of the vaccination campaign. […] And that there is currently no evidence that these incidents are related to the vaccine. ”

An American loan is on the horizon

With the presence of the AstraZeneca vaccine not yet approved in the United States, the Biden administration is working on a “loan” scheme that could allow Canada to get 1.5 million doses, Al Bab said. – White House speech by Jane Saki, Thursday.

Basically, Canada will receive 1.5 million doses from the United States and return the favor later. The office of Federal Supply Minister Anita Anand confirmed that the “trade” agreement is under negotiation.

The truth is, the epidemic knows no boundaries. Ensuring that our neighbors are able to contain the virus is a critical step, ”a White House spokesperson said, without providing details on the timeline for these potential deliveries.

Resumption of vaccination in Europe

France and Italy announced the resumption of vaccination with the AstraZeneca vaccine, pending at the time of the investigation, starting Friday.

Norway and Sweden decided to wait. A Norwegian medical team said Thursday that they have seen a link between the AstraZeneca vaccine and the clots seen in critically ill patients. The European Medicines Agency said that this ingredient was not included in the European investigation that ended Wednesday evening, but it will be part of the follow-up.

With Agence France-Presse

Leave a Reply

Your email address will not be published.